Brief: Calliditas Therapeutics Q3 Oper Loss At SEK 36.2 Mln
14/11/2022 06:05
Nov 14 (Reuters) - Calliditas Therapeutics AB CALTX.ST :
* Q3 NET SALES AMOUNTED TO SEK 260.1 MILLION
* Q3 OPERATING LOSS AMOUNTED TO SEK 36.2 MILLION
Source text for Eikon: ID:nWkr9sLHJs
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations